• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROGENIKA BIOPHARMA, S.A ID CORE XT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROGENIKA BIOPHARMA, S.A ID CORE XT Back to Search Results
Model Number 1021720000
Device Problems False Negative Result (1225); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/09/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation is still on-going.No conclusion is available for this malfunction.
 
Event Description
The customer reported a possible discrepancy.The serological phenotype was m+ (upper case) but when tested with id core xt resulted phenotype was m- (upper case).
 
Manufacturer Narrative
Corrected data: h3, h6.Additional data: b4, b6, g3, g6, h2, h10.B6: the genomic dna sample was sent to grifols ih center for dna sequencing of gypa exons 1 to 7.The variant gypa: c.136+58t in heterozygous was detected on intron 2 of the gene affecting the binding region of id core xt exon 2 reverse primer.The id core xt predicted genotype for this sample was gypa*n homozygous with an associated predicted phenotype m-n+ (upper case), but the dna sequencing detects the genotype gypa*m(c.136+58t), gypa*n with a predicted phenotype m+n+ (upper case), consistent with serology result m+ (upper case).This rare variant is not described in the literature and affects to the detection of the gypa*m allele by id core xt.Id core xt predicted genotype result for this sample was gypa*n, but according to the sequencing result and the m positive serology data , the predicted genotype is gypa*m(c.136+58t), gypa*n associated with a predicted phenotype m positive.This false m negative result obtained by id core xt is considered a discrepant result and then a malfunction.This case report is associated with limitation 9 of id core xt assay described in the id core xt package insert.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ID CORE XT
Type of Device
ID CORE XT
Manufacturer (Section D)
PROGENIKA BIOPHARMA, S.A
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP  48160
Manufacturer (Section G)
PROGENIKA BIOPHARMA, S.A
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP   48160
Manufacturer Contact
diego tejedor
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP   48160
MDR Report Key12516380
MDR Text Key272905191
Report Number3006413195-2021-00008
Device Sequence Number1
Product Code PEP
UDI-Device Identifier08437013457019
UDI-Public(01)08437013457019(17)220205(10)0203000023
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP170154
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/05/2022
Device Model Number1021720000
Device Catalogue Number1021720000
Device Lot Number0203000023
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 08/23/2021
Initial Date FDA Received09/22/2021
Supplement Dates Manufacturer Received10/21/2021
Supplement Dates FDA Received11/19/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-